Patent · US Active

Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions

US9199998B2 · kind B2 · utility

26Cited by

117References

10Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Waldemar Pfrengle · Seibersbach, DE
Markus Frank · Baden-Baden, DE
Thomas KLEIN · Radolfzell, DE

Key dates

Filing date	Dec 23, 2014
Grant date	Dec 1, 2015
Priority date	—
Expiry date	Dec 23, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D473/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to substituted quinazolines of formula (I) wherein X and Y are defined as in claim 1, the tautomers, stereoisomers, mixtures and salts thereof, which have valuable pharmacological properties, particularly an inhibitory effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.